Treatment of Early Syphilis with Azithromycin
- 1 January 2000
- journal article
- clinical trial
- Published by Taylor & Francis in Journal of Chemotherapy
- Vol. 12 (3) , 240-243
- https://doi.org/10.1179/joc.2000.12.3.240
Abstract
An open, noncomparative study was performed to establish the efficacy of azithromycin in the treatment of early syphilis. Sixteen patients were treated with oral azithromycin: 1g the first day and then 500 mg for the following 8 days. Two patients were excluded from the study, leaving 14 patients for the evaluation of the efficacy. Venereal Disease Research Laboratory (VDRL) negativity was observed in 3 out of 6 patients treated for primary syphilis after 3 months and in all patients after 6 months. Two of 8 patients treated for manifest or early latent secondary syphilis had VDRL negativity after 3 months and 4 patients after 6 months.This study demonstrates that azithromycin is effective in the treatment of early syphilis. Two patients experienced gastrointestinal side effects which did not require treatment interruption.Keywords
This publication has 4 references indexed in Scilit:
- SYPHILISDermatologic Clinics, 1998
- Epidemics of syphilis in the Russian Federation: trends, origins, and priorities for controlThe Lancet, 1997
- Sexually transmitted diseases in Estonia: past and presentInternational Journal of STD & AIDS, 1997
- Pilot Study of Azithromycin for Treatment of Primary and Secondary SyphilisClinical Infectious Diseases, 1994